Search for: "Corporal Holman"
Results 81 - 100
of 102
Sorted by Relevance
|
Sort by Date
15 Mar 2008, 7:00 am
Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa: (Afro-IP),Namibia to adopt competition… [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
12 Sep 2008, 2:33 pm
: (IPRoo), Review of National Innovation System – Key points for corporate counsel: (Mallesons Stephen Jaques), Review of National Innovation System recommends creative commons: (creativecommons.org), Review of Innovation System released: (IP Menu News), What [right]’s in a [business] name: Westpac Banking Corporation v McMillan & Melbas On The Park Pty Ltd (formerly Credit Systems Australia Pty Ltd): (Australian Trade Marks Law Blog), Senator Kim Carr… [read post]
7 Jun 2019, 3:00 am
Craig Holman, who lobbies on ethics, campaign finance, and lobbying on behalf of Public Citizen, said it is “heartening” that Cruz and Ocasio-Cortez moved to bridge the deep partisan divide. [read post]
30 Jul 2018, 10:44 am
(Yet another rock star Stanford fellow, with training in law and philosophy and interests in IP, health law, and corporations. [read post]
20 Dec 2023, 5:00 am
In the 1980s, the PTO granted the Chiron Corporation broad genus protection for antibodies that bind to HER2, a protein that helps breast cancer cells grow. [read post]
18 Oct 2010, 3:07 am
A-1 Tool (Chicago IP Litigation Blog) US Patents – Lawsuits and strategic steps Ko-Am Corporation – ALJ grants motion to terminate based on consent order in Electronic Paper Towel Dispenser Investigation (ITC 337 Update) Leviton Manufacturing – ITC institutes investigation (337-TA-739) regarding Certain Ground Fault Circuit Interrupters (ITC Law Blog) Lexmark – Commission institutes Inv. [read post]
18 Jan 2024, 4:56 am
Jordyn Holman and Gaya Gupta report for the New York Times. [read post]
4 Nov 2022, 4:00 am
Perkins Coie Dials Back Politics, Doubles Down on Corporate Work Bloomberg Government – Justin Wise | Published: 11/2/2022 Perkins Coie, the law firm that has long been a top adviser to Democrats, is looking to expand its work for tech and emerging companies while pulling back from politics. [read post]
21 Dec 2009, 3:06 am
To head off the complaint of some last year respecting AALS programming of interest to specialists in international, comparative, and transnational law -- a complaint undercut in this 11-month-old post -- it's our pleasure to offer a list of all such events on the program of the 2010, annual meeting of the Association of American Law Schools, to be held January 6-10 in New Orleans. [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb),US: Dr Robert Shapiro discusses follow-on biologics report: (Patent Docs),US: New report identifies $387 billion in savings from generic biologics: (Holman's Biotech IP Blog),US: Can approval of biogenerics really save money? [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries… [read post]
7 Jun 2024, 3:00 am
The reimbursement scheme’s lack of receipt requirements is a “ridiculous loophole,” said Craig Holman, a lobbyist for Public Citizen. [read post]
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent Office releases… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
